BC-78-NC89_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, [(1R,3R)-1-methyl-1-(3-phenylpropyl)piperidin-1-ium-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate, Muscarinic M3 Antagonists;Muscarinic M1 Antagonists;Muscarinic M2 Antagonists targeting CHRM3 (Novartis, 11191883)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/11191883
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the BC-78-NC89_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL31 ribosomal protein L31 0.661259
RPS13 ribosomal protein S13 0.447272
CCDC81 coiled-coil domain containing 81 0.272252
NLRP4 NLR family, pyrin domain containing 4 0.271042
ELOB elongin B 0.271042
KLRC3 killer cell lectin-like receptor subfamily C, member 3 0.264513
RPS29 ribosomal protein S29 0.2093

decreased expression

Symbol Name Standardized Value
TMED9 transmembrane emp24 protein transport domain containing 9 -0.271042
PPP2R1A protein phosphatase 2, regulatory subunit A, alpha -0.271042
P4HB prolyl 4-hydroxylase, beta polypeptide -0.268506
PCDHGA1 protocadherin gamma subfamily A, 1 -0.246178
PRKCSH protein kinase C substrate 80K-H -0.241518
SMG1 SMG1 phosphatidylinositol 3-kinase-related kinase -0.2093